Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells

被引:21
|
作者
Long, Joseph [1 ,2 ]
Hoban, Megan D. [1 ]
Cooper, Aaron R. [3 ]
Kaufman, Michael L. [1 ]
Kuo, Caroline Y. [4 ]
Campo-Fernandez, Beatriz [1 ]
Lumaquin, Dianne [1 ]
Hollis, Roger P. [1 ]
Wang, Xiaoyan [5 ]
Kohn, Donald B. [1 ,6 ]
Romero, Zulema [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 3146 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA
[2] Calif State Univ Northridge, Biol Dept, Northridge, CA 91330 USA
[3] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy & Immunol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA
关键词
ZINC-FINGER NUCLEASES; SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELLS; RETROVIRAL VECTOR; BCL11A KNOCKDOWN; COPY NUMBER; DISEASE; THERAPY; CRISPR-CAS9; THALASSEMIA;
D O I
10.1016/j.ymthe.2017.11.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of engineered nucleases combined with a homologous DNA donor template can result in targeted gene correction of the sickle cell disease mutation in hematopoietic stem and progenitor cells. However, because of the high homology between the adjacent human beta- and delta-globin genes, off-target cleavage is observed at delta-globin when using some endonucleases targeted to the sickle mutation in beta-globin. Introduction of multiple double-stranded breaks by endonucleases has the potential to induce intergenic alterations. Using a novel droplet digital PCR assay and high-throughput sequencing, we characterized the frequency of rearrangements between the beta- and delta-globin paralogs when delivering these nucleases. Pooled CD34(+) cells and colony-forming units from sickle bone marrow were treated with nuclease only or including a donor template and then analyzed for potential gene rearrangements. It was observed that, in pooled CD34(+) cells and colony-forming units, the intergenic beta-delta-globin deletion was the most frequent rearrangement, followed by inversion of the intergenic fragment, with the inter-chromosomal translocation as the least frequent. No rearrangements were observed when endonuclease activity was restricted to on-target beta-globin cleavage. These findings demonstrate the need to develop site-specific endonucleases with high specificity to avoid unwanted gene alterations.
引用
收藏
页码:468 / 479
页数:12
相关论文
共 50 条
  • [1] Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles
    Yu, Kyung-Rok
    Natanson, Hannah
    Dunbar, Cynthia E.
    HUMAN GENE THERAPY, 2016, 27 (10) : 729 - 740
  • [2] Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
    Park, So Hyun
    Lee, Ciaran M.
    Dever, Daniel P.
    Davis, Timothy H.
    Camarena, Joab
    Srifa, Waracharee
    Zhang, Yankai
    Paikari, Alireza
    Chang, Alicia K.
    Porteus, Matthew H.
    Sheehan, Vivien A.
    Bao, Gang
    NUCLEIC ACIDS RESEARCH, 2019, 47 (15) : 7955 - 7972
  • [3] Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells
    Cromer, M. Kyle
    Camarena, Joab
    Martin, Renata M.
    Lesch, Benjamin J.
    Vakulskas, Christopher A.
    Bode, Nicole M.
    Kurgan, Gavin
    Collingwood, Michael A.
    Rettig, Garrett R.
    Behlke, Mark A.
    Lemgart, Viktor T.
    Zhang, Yankai
    Goyal, Ankush
    Zhao, Feifei
    Ponce, Ezequiel
    Srifa, Waracharee
    Bak, Rasmus O.
    Uchida, Naoya
    Majeti, Ravindra
    Sheehan, Vivien A.
    Tisdale, John F.
    Dever, Daniel P.
    Porteus, Matthew H.
    NATURE MEDICINE, 2021, 27 (04) : 677 - 687
  • [4] Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
    Anurogo, Dito
    Budi, Nova Yuli Prasetyo
    Mai-Huong Thi Ngo
    Huang, Yen-Hua
    Pawitan, Jeanne Adiwinata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [5] Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells
    Murugesan, Ramya
    Karuppusamy, Karthik V.
    Marepally, Srujan
    Thangavel, Saravanabhavan
    FRONTIERS IN GENOME EDITING, 2023, 5
  • [6] Gene editing & stem cells
    Harrison, Patrick T.
    Hoppe, Nils
    Martin, Ulrich
    JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (01) : 10 - 16
  • [7] Transfection of Human Hematopoietic Stem Cells by a Gene Targeting Construct Containing the β-Globin Gene
    Shaikhpoor, Mojhgan
    Khanahmad, Hossein
    Shokrgozar, Mohamadali
    Soleimani, Masood
    Zainali, Bahman
    Kamali, Esmat
    Moosavi, Seyedeh Soghra
    Zeinali, Sirous
    YAKHTEH, 2010, 12 (02): : 199 - 206
  • [8] Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair
    Lomova, Anastasia
    Clark, Danielle N.
    Campo-Fernandez, Beatriz
    Flores-Bjurstrom, Carmen
    Kaufman, Michael L.
    Fitz-Gibbon, Sorel
    Wang, Xiaoyan
    Miyahira, Eric Y.
    Brown, Devin
    DeWitt, Mark A.
    Corn, Jacob E.
    Hollis, Roger P.
    Romero, Zulema
    Kohn, Donald B.
    STEM CELLS, 2019, 37 (02) : 284 - 294
  • [9] Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
    Azhagiri, Manoj Kumar K.
    Babu, Prathibha
    Venkatesan, Vigneshwaran
    Thangavel, Saravanabhavan
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [10] Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
    Ferrari, Samuele
    Vavassori, Valentina
    Canarutto, Daniele
    Jacob, Aurelien
    Castiello, Maria Carmina
    Javed, Attya Omer
    Genovese, Pietro
    FRONTIERS IN GENOME EDITING, 2021, 3